Current Liabilities

Derivative liabilities

Abbott Derivative liabilities decreased by 62.7% to $19.00M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2024
Last reportedQ4 2025Feb 20, 2026

How to read this metric

An increase in derivative liabilities often signals adverse market movements against the company's hedging positions or an increase in hedging activity.

Detailed definition

This represents the aggregate fair value of all derivative financial instruments that are currently in a net loss positi...

Peer comparison

Highly comparable across multinational peers that utilize derivatives to manage global currency and interest rate exposures.

Metric ID: fin_derivative_liabilities

Historical Data

2 periods
 Q4 '24Q4 '25
Value$51.00M$19.00M
QoQ Change-62.7%
YoY Change-62.7%
Range$19.00M$51.00M
Avg YoY Growth-62.7%
Median YoY Growth-62.7%

Derivative liabilities at Other Companies

Frequently Asked Questions

What is Abbott's derivative liabilities?
Abbott (ABT) reported derivative liabilities of $19.00M in Q4 2025.
What does derivative liabilities mean?
The total value the company would have to pay to close out all its derivative contracts that are currently losing money.